TR200100769T2 - A new composition - Google Patents
A new compositionInfo
- Publication number
- TR200100769T2 TR200100769T2 TR2001/00769T TR200100769T TR200100769T2 TR 200100769 T2 TR200100769 T2 TR 200100769T2 TR 2001/00769 T TR2001/00769 T TR 2001/00769T TR 200100769 T TR200100769 T TR 200100769T TR 200100769 T2 TR200100769 T2 TR 200100769T2
- Authority
- TR
- Turkey
- Prior art keywords
- composition
- compound component
- mood disorders
- new composition
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Bulus birinci bilesik komponenti (a) (R) -3-N,N-disiklo butil amino -8-floro -3,4- dihidro -2H-1-benzopiran -5-karboksiamid hidrojen (2R, 3R)-tartrat monohidrat ve serbest baz veya farmasötik bir tuz ve/veya onun bir solvati formunda, bunun bir rasemati veya enantiomeri olarak ikinci bilesik komponenti (b) 1- [3- (dimetil amino) propil] -1- (p-florofenil) -5-Fitalankarbonitrilden, mütesekkil bir bilesimle, bunun hazirlanmasi, bu bilesimi ihtiva eden farmasötik formülasyonlar, bu bilesimin ve bu bilesimi ihtiva eden bir setin duygu durum bozukluklari ve anksiete bozukluklari gibi duygu bozukluklarinin tedavisinde kullanimi ve bunun bir yöntemiyle ilgilidir.The first compound component of the invention (a) (R) -3-N, N-dicyclo butyl amino -8-fluoro -3,4-dihydro -2H-1-benzopyran -5-carboxamide hydrogen (2R, 3R) -tartrate monohydrate and the second compound component (b) 1- [3- (dimethyl amino) propyl] -1- (p-fluorophenyl) -5-Phthalanetarbonitrile in the form of a free base or a pharmaceutical salt and / or a solvate thereof, as a racemate or enantiomer thereof, with a mutual composition, its preparation relates to the use of pharmaceutical formulations containing this composition, the use of this combination and a set containing this composition in the treatment of mood disorders such as mood disorders and anxiety disorders and a method thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803157A SE9803157D0 (en) | 1998-09-16 | 1998-09-16 | A new composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200100769T2 true TR200100769T2 (en) | 2001-11-21 |
Family
ID=20412628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/00769T TR200100769T2 (en) | 1998-09-16 | 1999-09-13 | A new composition |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1121119A1 (en) |
| JP (1) | JP2002524509A (en) |
| KR (1) | KR20010099648A (en) |
| CN (1) | CN1317963A (en) |
| AR (1) | AR023657A1 (en) |
| AU (1) | AU6378199A (en) |
| BR (1) | BR9913765A (en) |
| CA (1) | CA2342585A1 (en) |
| CZ (1) | CZ2001962A3 (en) |
| EE (1) | EE200100156A (en) |
| HU (1) | HUP0103569A3 (en) |
| ID (1) | ID28359A (en) |
| IL (1) | IL141520A0 (en) |
| IS (1) | IS5877A (en) |
| NO (1) | NO20011313L (en) |
| PL (1) | PL346769A1 (en) |
| SE (1) | SE9803157D0 (en) |
| SK (1) | SK3272001A3 (en) |
| TR (1) | TR200100769T2 (en) |
| WO (1) | WO2000015219A1 (en) |
| ZA (1) | ZA200101951B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR021155A1 (en) | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | TREATMENT OF NEUROTIC DISORDERS |
| US7307087B2 (en) * | 2000-10-13 | 2007-12-11 | Neurosearch A/S | Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| WO2006038217A1 (en) * | 2004-10-05 | 2006-04-13 | Strides Acrolab Limited | An improved drug delivery system of citalopram hydrobromide and process for producing the same |
| WO2006123243A2 (en) | 2005-05-20 | 2006-11-23 | Aurobindo Pharma Limited | Pharmaceutical dosage forms comprising escitalopram in form of granules |
| TW200812993A (en) * | 2006-05-02 | 2008-03-16 | Lundbeck & Co As H | New uses of escitalopram |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9501567D0 (en) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
-
1998
- 1998-09-16 SE SE9803157A patent/SE9803157D0/en unknown
-
1999
- 1999-09-13 CA CA002342585A patent/CA2342585A1/en not_active Abandoned
- 1999-09-13 CN CN99811007A patent/CN1317963A/en active Pending
- 1999-09-13 IL IL14152099A patent/IL141520A0/en unknown
- 1999-09-13 HU HU0103569A patent/HUP0103569A3/en unknown
- 1999-09-13 ID IDW20010580A patent/ID28359A/en unknown
- 1999-09-13 CZ CZ2001962A patent/CZ2001962A3/en unknown
- 1999-09-13 EE EEP200100156A patent/EE200100156A/en unknown
- 1999-09-13 BR BR9913765-8A patent/BR9913765A/en not_active Application Discontinuation
- 1999-09-13 WO PCT/SE1999/001598 patent/WO2000015219A1/en not_active Application Discontinuation
- 1999-09-13 EP EP99951320A patent/EP1121119A1/en not_active Withdrawn
- 1999-09-13 JP JP2000569803A patent/JP2002524509A/en active Pending
- 1999-09-13 SK SK327-2001A patent/SK3272001A3/en unknown
- 1999-09-13 AU AU63781/99A patent/AU6378199A/en not_active Abandoned
- 1999-09-13 TR TR2001/00769T patent/TR200100769T2/en unknown
- 1999-09-13 PL PL99346769A patent/PL346769A1/en unknown
- 1999-09-13 KR KR1020017003338A patent/KR20010099648A/en not_active Application Discontinuation
- 1999-09-15 AR ARP990104627A patent/AR023657A1/en unknown
-
2001
- 2001-03-05 IS IS5877A patent/IS5877A/en unknown
- 2001-03-08 ZA ZA200101951A patent/ZA200101951B/en unknown
- 2001-03-15 NO NO20011313A patent/NO20011313L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200101951B (en) | 2002-06-10 |
| CN1317963A (en) | 2001-10-17 |
| SE9803157D0 (en) | 1998-09-16 |
| IS5877A (en) | 2001-03-05 |
| ID28359A (en) | 2001-05-17 |
| NO20011313D0 (en) | 2001-03-15 |
| KR20010099648A (en) | 2001-11-09 |
| JP2002524509A (en) | 2002-08-06 |
| IL141520A0 (en) | 2002-03-10 |
| BR9913765A (en) | 2001-06-05 |
| PL346769A1 (en) | 2002-02-25 |
| EP1121119A1 (en) | 2001-08-08 |
| EE200100156A (en) | 2002-08-15 |
| CA2342585A1 (en) | 2000-03-23 |
| CZ2001962A3 (en) | 2001-08-15 |
| AU6378199A (en) | 2000-04-03 |
| SK3272001A3 (en) | 2001-09-11 |
| NO20011313L (en) | 2001-05-16 |
| WO2000015219A1 (en) | 2000-03-23 |
| AR023657A1 (en) | 2002-09-04 |
| HUP0103569A2 (en) | 2002-02-28 |
| HUP0103569A3 (en) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9501567D0 (en) | A new combination | |
| NO20034230D0 (en) | 1,2,3,4-tetrahydroisoquinoline derivatives as urotensin II receptor antagonists | |
| BRPI0408681A (en) | compounds, pharmaceutical compositions, use of a 1,2,3,4-tetrahydroisoquinoline derivative, method for treating or preventing disease, process for the manufacture of pharmaceutical compositions, and use of one or more compounds | |
| ATE496884T1 (en) | SULPHONYLAMINOACETIC ACID DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONISTS | |
| ATE286500T1 (en) | 1,2,3,4-TETRAHYDROISOCINOLINE DERIVATIVES | |
| SE0101675D0 (en) | Novel composition | |
| RS50814B (en) | Tartarate salts of 5,8,14-triazatetracyclo(10.3.1.02,11.04,9 )-hexadeca-2(11)3,5,7,9-pentaene and pharmaceutical compositions thereof | |
| YU40701A (en) | Piperidines as ccr5 modulators | |
| NO20042964L (en) | Spiroazacyclic compounds as monoamine receptor modulators | |
| DE60131730D1 (en) | AGONISTS AND ANTAGONISTS FOR THE LPA RECEPTOR AND APPLICATION METHODS | |
| BG108225A (en) | Thiohydantoins and use thereof for treating diabetes | |
| NO20042844L (en) | 4- (piperidyl- and pyrrolidyl-alkyl-ureido) -quinolines as uprotensin II receptor antagonists | |
| TR200403020T2 (en) | (S) -4-Amino-5-chloro-2-methoxy-N- (1- (1- (2-tetrahydrofurylcarbonyl) -4-piperidinylmethyl) -4-piperidinyl) benzamide, the process for its preparation and pharmaceutical composition comprising the intermediate thereof | |
| ATE479655T1 (en) | NEW AMINOAZETIDINE, AMINOPYRROLIDINE AND AMINOPIPERIDINE DERIVATIVES | |
| FR2806299B1 (en) | COMPOSITIONS FOR DYEING KERATINIC FIBERS CONTAINING PYRROLIDINYL GROUPED PARAPHENYLENEDIAMINE DERIVATIVES | |
| TR200000737T2 (en) | Substituted chroma derivatives. | |
| PT1140031E (en) | PHARMACEUTICAL PREPARATION OF CONTROLLED LIBERATION WITH TILIDINE MESYLATE AS AN ACTIVE SUBSTANCE | |
| SE0102055D0 (en) | New Compounds | |
| TR200100769T2 (en) | A new composition | |
| ATE369348T1 (en) | CYCLIZED BENZAMIDE NEUROKININ ANTAGONISTS FOR USE IN THERAPY | |
| ATE386525T1 (en) | 3-SUBSTITUTED 6,7-DIHYDROXYTETRAHYDROISOCINOLINE DERIVATIVES FOR USE AS ANTIBATERAL AGENTS | |
| SE9904404L (en) | New composition | |
| DK1355626T3 (en) | Veterinary, dermatological composition | |
| BRPI0407529A (en) | use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain | |
| SE9803158D0 (en) | A new composition |